Accurate molecular classification of mcrpc for precision treatment through multiomic analysis of circulating tumor DNA.
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110513
- Recipient
-
Fred Hutchinson Cancer Research Center UEI HMSNCM57QNR5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,036,233
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Seattle, WA 98109, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $1,036,233 Project Grant to the Fred Hutchinson Cancer Research Center under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 through June 2024 to develop more precise molecular classification and targeted treatment of metastatic castration-resistant prostate cancer (MCRPC) through multi-omic analysis of circulating tumor DNA (ctDNA). By leveraging ctDNA analysis, the research aims to transform care for service members and the public through innovative medical solutions applicable both on the battlefield and in civilian healthcare settings.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $1,036,233 |
Quick answers
Who received award W81XWH2110513?
W81XWH2110513 was awarded to Fred Hutchinson Cancer Research Center by Defense Health Agency (Department of Defense) on July 1, 2021.
How much is award W81XWH2110513 worth?
$1,036,233 has been obligated on W81XWH2110513.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award